6.26
price up icon4.86%   0.29
pre-market  Pre-mercato:  6.05   -0.21   -3.35%
loading
Precedente Chiudi:
$5.97
Aprire:
$6
Volume 24 ore:
302.44K
Relative Volume:
0.66
Capitalizzazione di mercato:
$353.28M
Reddito:
-
Utile/perdita netta:
$-72.89M
Rapporto P/E:
-2.5868
EPS:
-2.42
Flusso di cassa netto:
$-68.47M
1 W Prestazione:
-5.44%
1M Prestazione:
+6.83%
6M Prestazione:
-17.31%
1 anno Prestazione:
-44.11%
Intervallo 1D:
Value
$6.00
$6.3988
Intervallo di 1 settimana:
Value
$5.9404
$6.63
Portata 52W:
Value
$3.555
$12.92

Astria Therapeutics Inc Stock (ATXS) Company Profile

Name
Nome
Astria Therapeutics Inc
Name
Telefono
617-349-1971
Name
Indirizzo
22 BOSTON WHARF ROAD, BOSTON
Name
Dipendente
78
Name
Cinguettio
Name
Prossima data di guadagno
2025-03-11
Name
Ultimi documenti SEC
Name
ATXS's Discussions on Twitter

Confronta ATXS con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
ATXS
Astria Therapeutics Inc
6.26 373.59M 0 -72.89M -68.47M -2.42
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
458.49 121.30B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
545.53 61.60B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
320.52 41.17B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
566.14 34.35B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
291.93 27.29B 3.81B -644.79M -669.77M -6.24

Astria Therapeutics Inc Stock (ATXS) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2025-04-29 Iniziato Cantor Fitzgerald Overweight
2025-01-31 Iniziato JMP Securities Mkt Outperform
2024-07-29 Iniziato TD Cowen Buy
2023-03-28 Iniziato Evercore ISI Outperform

Astria Therapeutics Inc Borsa (ATXS) Ultime notizie

pulisher
03:12 AM

What drives Astria Therapeutics Inc. stock priceExceptional portfolio growth - jammulinksnews.com

03:12 AM
pulisher
Jul 21, 2025

What analysts say about Astria Therapeutics Inc. stockRobust financial gains - Autocar Professional

Jul 21, 2025
pulisher
Jul 20, 2025

Is Astria Therapeutics Inc. a good long term investmentGame-changing returns - Autocar Professional

Jul 20, 2025
pulisher
Jul 19, 2025

Astria Therapeutics Inc. Stock Analysis and ForecastDynamic growth stocks - Autocar Professional

Jul 19, 2025
pulisher
Jul 19, 2025

Published on: 2025-07-19 19:06:02 - jammulinksnews.com

Jul 19, 2025
pulisher
Jul 18, 2025

Will Astria Therapeutics Inc. stock split in the near futureFree Stock Market Trend Analysis - Newser

Jul 18, 2025
pulisher
Jul 16, 2025

why astria therapeutics inc. stock attracts strong analyst attentionPortfolio Boosting Stock Alerts - Newser

Jul 16, 2025
pulisher
Jul 16, 2025

How Astria Therapeutics Inc. stock performs during market volatilityTechnical Breakout List - Newser

Jul 16, 2025
pulisher
Jul 15, 2025

What makes Astria Therapeutics Inc. stock price move sharplyFree Access to Stock Community - beatles.ru

Jul 15, 2025
pulisher
Jul 15, 2025

Why Astria Therapeutics Inc. stock attracts strong analyst attentionFree Stock Selection with 300% Return - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

Astria: Betting On Navenibart In The Crowded HAE Arena - Seeking Alpha

Jul 15, 2025
pulisher
Jul 09, 2025

Astria Therapeutics (ATXS) Soars 5.62% on Positive Trial Results - AInvest

Jul 09, 2025
pulisher
Jul 08, 2025

Astria Therapeutics Inc (ATXS) Stock: Uncovering 52-Week Market Trends - investchronicle.com

Jul 08, 2025
pulisher
Jul 07, 2025

Astria Therapeutics to Present at Upcoming 2025 US Hereditary Angioedema Association National Summit - BioSpace

Jul 07, 2025
pulisher
Jul 07, 2025

Astria Therapeutics, Inc. (NASDAQ:ATXS) Given Average Recommendation of “Buy” by Analysts - Defense World

Jul 07, 2025
pulisher
Jul 03, 2025

Astria Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)July 2, 2025 - BioSpace

Jul 03, 2025
pulisher
Jun 29, 2025

Trading (ATXS) With Integrated Risk Controls - news.stocktradersdaily.com

Jun 29, 2025
pulisher
Jun 18, 2025

(ATXS) Trading Report - news.stocktradersdaily.com

Jun 18, 2025
pulisher
Jun 18, 2025

Astria Therapeutics to Participate in Upcoming Oppenheimer Innovators in Immunology & Inflammation Summit - BioSpace

Jun 18, 2025
pulisher
Jun 18, 2025

Astria Therapeutics to Participate in Upcoming Oppenheimer Innov - GuruFocus

Jun 18, 2025
pulisher
Jun 18, 2025

Astria CEO Discusses Breakthrough Dermatology Treatments at Major Oppenheimer Summit - Stock Titan

Jun 18, 2025
pulisher
Jun 16, 2025

Astria Therapeutics Announces Positive Initial Results from the ALPHA-SOLAR Long-Term Open-Label Trial of Navenibart in Hereditary Angioedema Patients at the European Academy of Allergy and Clinical Immunology Annual Congress - BioSpace

Jun 16, 2025
pulisher
Jun 15, 2025

Brokerages Set Astria Therapeutics, Inc. (NASDAQ:ATXS) Target Price at $30.00 - Defense World

Jun 15, 2025
pulisher
Jun 15, 2025

HC Wainwright Reaffirms “Buy” Rating for Astria Therapeutics (NASDAQ:ATXS) - Defense World

Jun 15, 2025
pulisher
Jun 14, 2025

Astria Therapeutics (ATXS) Receives Reiterated Buy Rating and $1 - GuruFocus

Jun 14, 2025
pulisher
Jun 13, 2025

Astria Therapeutics (ATXS) Reports Promising Results for Navenib - GuruFocus

Jun 13, 2025
pulisher
Jun 13, 2025

Astria Therapeutics Announces Positive Initial Results from the - GuruFocus

Jun 13, 2025
pulisher
Jun 13, 2025

Astria Therapeutics Says New Data Back Navenibart Dose Regimen for Hereditary Angioedema - MarketScreener

Jun 13, 2025
pulisher
Jun 13, 2025

California State Teachers Retirement System Increases Holdings in Astria Therapeutics, Inc. (NASDAQ:ATXS) - Defense World

Jun 13, 2025
pulisher
Jun 13, 2025

Two Sigma Investments LP Sells 2,042 Shares of Astria Therapeutics, Inc. (NASDAQ:ATXS) - Defense World

Jun 13, 2025
pulisher
Jun 13, 2025

Astria reports positive results from HAE drug trial - Investing.com

Jun 13, 2025

Astria Therapeutics Inc Azioni (ATXS) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$21.69
price down icon 0.87%
$35.65
price up icon 0.17%
$102.78
price up icon 0.22%
$26.34
price up icon 0.53%
$108.91
price down icon 1.01%
biotechnology ONC
$291.93
price down icon 0.89%
Capitalizzazione:     |  Volume (24 ore):